BioVie Inc.

NASDAQ: BIVI · Healthcare · Biotechnology

PublicHQ Carson City, NV · Carson City (Independent City)CIK 0001580149Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 38DQ —GM —SS 36

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, filing timeliness · ↓ Piotroski F, Altman-Z

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$17.5M

Employees

as of 2026-08-22

Market cap

$14.7M

as of 2026-08-22

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$17.5M-$17.5M2025

Operating income-$18.1M-$18.1M2025

Total assets$21.6M$21.6M2025

Liabilities$2.6M$2.6M2025

Equity$19.0M$19.0M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is BioVie Inc.’s financial profile?

BioVie Inc. earned -$17.5M in FY2025 net income.

Peers · Healthcare

Optimi Health Corp.——Akari Therapeutics, Plc——CS Diagnostics Corp.——Passage Bio, Inc.——Anebulo Pharmaceuticals, Inc.——Intensity Therapeutics, Inc.——

Neighbors

Carson City (Independent City) →

Victor Mining Industry Group Inc.$324.9k——Flywheel Advanced Technology, Inc.$1.4M12D Anything Technologies Media, Inc.$033D Atlantis Technology Group$0——Franklin Mining, Inc.$0——Absolute Health and Fitness, Inc.——

Key facts

CEOCuong Viet Do

SectorHealthcare

IndustryBiotechnology

HeadquartersCarson City, NV

ExchangeNASDAQ: BIVI

Employees13

IPO date2020-09-18

Latest filings

10-K2026-08-13 8-K2026-08-06 10-Q2026-05-11 10-Q2026-02-06 8-K2025-11-13 8-K2025-11-12 10-Q2025-11-10 DEF 14A2025-09-25

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.